A Recombinant Chimeric Protein Specifically Induces Mutant KRAS Degradation and Potently Inhibits Pancreatic Tumor Growth

Oncotarget- United States

doi 10.18632/oncotarget.9996

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Impact Journals, LLC


Related search